These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33838618)

  • 1. Changes in drug use in European cities during early COVID-19 lockdowns - A snapshot from wastewater analysis.
    Been F; Emke E; Matias J; Baz-Lomba JA; Boogaerts T; Castiglioni S; Campos-Mañas M; Celma A; Covaci A; de Voogt P; Hernández F; Kasprzyk-Hordern B; Laak TT; Reid M; Salgueiro-González N; Steenbeek R; van Nuijs ALN; Zuccato E; Bijlsma L
    Environ Int; 2021 Aug; 153():106540. PubMed ID: 33838618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology.
    Estévez-Danta A; Bijlsma L; Capela R; Cela R; Celma A; Hernández F; Lertxundi U; Matias J; Montes R; Orive G; Prieto A; Santos MM; Rodil R; Quintana JB
    Sci Total Environ; 2022 Aug; 836():155697. PubMed ID: 35523346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug consumption in German cities and municipalities during the COVID-19 lockdown: a wastewater analysis.
    Oertel R; Schubert S; Helm B; Mayer R; Dumke R; El-Armouche A; Renner B
    Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):1061-1074. PubMed ID: 36633617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial variations in the consumption of illicit stimulant drugs across Australia: A nationwide application of wastewater-based epidemiology.
    Lai FY; O'Brien J; Bruno R; Hall W; Prichard J; Kirkbride P; Gartner C; Thai P; Carter S; Lloyd B; Burns L; Mueller J
    Sci Total Environ; 2016 Oct; 568():810-818. PubMed ID: 27267725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles and changes in stimulant use in Belgium in the period of 2011-2015.
    Been F; Lai FY; Kinyua J; Covaci A; van Nuijs ALN
    Sci Total Environ; 2016 Sep; 565():1011-1019. PubMed ID: 27251771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The embodiment of wastewater data for the estimation of illicit drug consumption in Spain.
    Bijlsma L; Picó Y; Andreu V; Celma A; Estévez-Danta A; González-Mariño I; Hernández F; López de Alda M; López-García E; Marcé RM; Miró M; Montes R; Pérez de San Román-Landa U; Pitarch E; Pocurull E; Postigo C; Prieto A; Rico A; Rodil R; Valcárcel Y; Ventura M; Quintana JB
    Sci Total Environ; 2021 Jun; 772():144794. PubMed ID: 33770873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
    Hahn RZ; Bastiani MF; Lizot LLF; Schneider A; da Silva Moreira IC; Meireles YF; Viana MF; do Nascimento CA; Linden R
    Chemosphere; 2022 Sep; 302():134907. PubMed ID: 35561781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatio-temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring.
    González-Mariño I; Baz-Lomba JA; Alygizakis NA; Andrés-Costa MJ; Bade R; Bannwarth A; Barron LP; Been F; Benaglia L; Berset JD; Bijlsma L; Bodík I; Brenner A; Brock AL; Burgard DA; Castrignanò E; Celma A; Christophoridis CE; Covaci A; Delémont O; de Voogt P; Devault DA; Dias MJ; Emke E; Esseiva P; Fatta-Kassinos D; Fedorova G; Fytianos K; Gerber C; Grabic R; Gracia-Lor E; Grüner S; Gunnar T; Hapeshi E; Heath E; Helm B; Hernández F; Kankaanpaa A; Karolak S; Kasprzyk-Hordern B; Krizman-Matasic I; Lai FY; Lechowicz W; Lopes A; López de Alda M; López-García E; Löve ASC; Mastroianni N; McEneff GL; Montes R; Munro K; Nefau T; Oberacher H; O'Brien JW; Oertel R; Olafsdottir K; Picó Y; Plósz BG; Polesel F; Postigo C; Quintana JB; Ramin P; Reid MJ; Rice J; Rodil R; Salgueiro-González N; Schubert S; Senta I; Simões SM; Sremacki MM; Styszko K; Terzic S; Thomaidis NS; Thomas KV; Tscharke BJ; Udrisard R; van Nuijs ALN; Yargeau V; Zuccato E; Castiglioni S; Ort C
    Addiction; 2020 Jan; 115(1):109-120. PubMed ID: 31642141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal monitoring of stimulants during the COVID-19 pandemic in Belgium through the analysis of influent wastewater.
    Boogaerts T; Quireyns M; De Prins M; Pussig B; De Loof H; Matheï C; Aertgeerts B; Van Coppenolle V; Fransen E; Covaci A; van Nuijs ALN
    Int J Drug Policy; 2022 Jun; 104():103679. PubMed ID: 35427945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illicit drug use in Reykjavik by wastewater-based epidemiology.
    Löve ASC; Ásgrímsson V; Ólafsdóttir K
    Sci Total Environ; 2022 Jan; 803():149795. PubMed ID: 34482138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triangulating Amsterdam's illicit stimulant use trends by wastewater analysis and recreational drug use monitoring.
    Ter Laak TL; Emke E; Benschop A; Nabben T; Béen F
    Forensic Sci Int; 2022 Nov; 340():111449. PubMed ID: 36150279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wastewater-based assessment of regional and temporal consumption patterns of illicit drugs and therapeutic opioids in Croatia.
    Krizman I; Senta I; Ahel M; Terzic S
    Sci Total Environ; 2016 Oct; 566-567():454-462. PubMed ID: 27232972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key Interpretation Challenges for Wastewater-Based Epidemiology of Illicit Drugs: A Norwegian Three-City Case Study.
    Bretteville-Jensen AL; Amundsen EJ; Mounteney J
    Eur Addict Res; 2022; 28(6):436-445. PubMed ID: 36137511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomeric profiling of chiral illicit drugs in a pan-European study.
    Castrignanò E; Yang Z; Bade R; Baz-Lomba JA; Castiglioni S; Causanilles A; Covaci A; Gracia-Lor E; Hernandez F; Kinyua J; McCall AK; van Nuijs ALN; Ort C; Plósz BG; Ramin P; Rousis NI; Ryu Y; Thomas KV; de Voogt P; Zuccato E; Kasprzyk-Hordern B
    Water Res; 2018 Mar; 130():151-160. PubMed ID: 29216482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of illicit drugs in wastewater and estimation of drugs of abuse in Adana Province, Turkey.
    Daglioglu N; Guzel EY; Kilercioglu S
    Forensic Sci Int; 2019 Jan; 294():132-139. PubMed ID: 30529037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illicit drug consumption estimated by wastewater analysis in different districts of Milan: A case study.
    Castiglioni S; Borsotti A; Riva F; Zuccato E
    Drug Alcohol Rev; 2016 Mar; 35(2):128-32. PubMed ID: 25545943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of illicit drugs in two wastewater treatment plants in the South of Italy.
    Cosenza A; Maida CM; Piscionieri D; Fanara S; Di Gaudio F; Viviani G
    Chemosphere; 2018 May; 198():377-385. PubMed ID: 29421753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of illicit stimulant drugs in Finland: a wastewater study in ten major cities.
    Kankaanpää A; Ariniemi K; Heinonen M; Kuoppasalmi K; Gunnar T
    Sci Total Environ; 2014 Jul; 487():696-702. PubMed ID: 24331163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids, stimulants, and depressant drugs in fifteen Mexican Cities: A wastewater-based epidemiological study.
    Cruz-Cruz C; Yargeau V; Vidaña-Perez D; Schilmann A; Pineda MA; Lobato M; Hernández-Avila M; Villatoro JA; Barrientos-Gutierrez T
    Int J Drug Policy; 2021 Feb; 88():103027. PubMed ID: 33212372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.